(31)P cardiac magnetic resonance spectroscopy during leg exercise at 3 Tesla.
Investigation of phosphorus ((31)P) magnetic resonance spectroscopy under stress conditions provides a non-invasive tool to examine alterations in cardiac high-energy phosphate metabolism that may not be evident at rest. Our aim was to establish cardiac (31)P MR spectroscopy during leg exercise at 3T. The increased field strength should provide a higher signal to noise ratio than at lower field strengths. Furthermore, relatively high temporal resolution at a sufficiently fine spatial resolution should be feasible. (31)P MR spectra were obtained with a 3D acquisition weighted chemical shift imaging sequence in 20 healthy volunteers at rest, during dynamic physiological leg exercise and after recovery at 3T. Haemodynamic measurements were made throughout and the rate pressure product calculated. With exercise, the mean heart rate increased by 73%, achieving a mean increase in rate pressure product of 115%. The corrected PCr/ATP ratio for subjects at rest was 2.02 +/- 0.43, exercise 2.14 +/- 0.67 (P = 0.54 vs. rest) and at recovery 2.03 +/- 0.52 (P = 0.91 vs. rest, P = 0.62 vs. exercise). A cardiac (31)P MR spectroscopy physiological exercise-recovery protocol is feasible at 3T. There was no significant change in high-energy cardiac phosphate metabolite concentrations in healthy volunteers at rest, during physiological leg exercise or during recovery. When applied to patients with heart disease, this protocol should provide insights into physiological and pathological cardiac metabolism.
Hudsmith
Lucy E
LE
The University of Oxford Centre for Clinical Magnetic Resonance Research, Department of Cardiovascular Medicine, Oxford, OX3 9DU, UK. lucyhudsmith@hotmail.com
Tyler
Damian J
DJ
Emmanuel
Yaso
Y
Petersen
Steffen E
SE
Francis
Jane M
JM
Watkins
Hugh
H
Clarke
Kieran
K
Robson
Matthew D
MD
Neubauer
Stefan
S
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D001794:Blood Pressure; D004734:Energy Metabolism; D015444:Exercise; D005260:Female; D006339:Heart Rate; D006801:Humans; D021621:Imaging, Three-Dimensional; D007866:Leg; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009119:Muscle Contraction; D018482:Muscle, Skeletal / Q000502:physiology*; D009206:Myocardium / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism; D010759:Phosphorus Isotopes
D010759:Phosphorus Isotopes; D010725:Phosphocreatine; D000255:Adenosine Triphosphate
Circulation. 1994 Apr;89(4):1709-16
8149536
Br Heart J. 1991 Jan;65(1):25-30
1993127
NMR Biomed. 2009 May;22(4):405-13
19023865
Circulation. 1997 Oct 7;96(7):2190-6
9337189
Magn Reson Med. 1995 Mar;33(3):427-31
7760712
J Am Coll Cardiol. 2008 May 13;51(19):1883-91
18466804
Am J Physiol. 1983 Aug;245(2):H354-62
6881368
Circulation. 1992 Dec;86(6):1810-8
1451253
Magn Reson Med. 1992 Aug;26(2):368-76
1513258
Magn Reson Med. 1992 Jun;25(2):260-72
1614310
Am J Physiol. 1994 May;266(5 Pt 2):H1959-70
8203595
Circulation. 1999 May 4;99(17):2261-7
10226091
Eur J Appl Physiol Occup Physiol. 1994;69(6):488-91
7713067
Circulation. 1997 Nov 4;96(9):2969-77
9386164
Comput Biol Med. 2001 Jul;31(4):269-86
11334636
J Heart Lung Transplant. 2002 May;21(5):522-9
11983541
Lancet. 1988 Sep 17;2(8612):692
2901555
Am J Cardiol. 1994 Mar 1;73(7):456-9
8141086
Circulation. 1978 Mar;57(3):549-56
624164
J Am Coll Cardiol. 2005 Apr 19;45(8):1235-42
15837255
Magn Reson Med. 1994 Jul;32(1):137-41
8084230
Circulation. 2003 Jun 24;107(24):3040-6
12810608
N Engl J Med. 1990 Dec 6;323(23):1593-600
2233948
J Am Coll Cardiol. 2003 May 21;41(10):1776-82
12767664
Arch Neurol. 2005 Apr;62(4):621-6
15824263
Acta Physiol Scand. 2003 Apr;177(4):467-72
12648164
J Am Coll Cardiol. 2006 Feb 21;47(4):781-8
16487845
Circulation. 1998 Feb 24;97(7):666-72
9495302
N Engl J Med. 2000 Mar 23;342(12):829-35
10727587
Radiology. 2001 Jun;219(3):637-43
11376247